Categories: News

CENTR Brands Corp. Now Sold at Mollie Stone’s Markets

Vancouver, British Columbia–(Newsfile Corp. – September 15, 2021) – CENTR Brands Corp. (the “Company“) (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) today announced that San Francisco Bay-area supermarket chain Mollie Stone’s Markets now sells both CENTR and CENTR Sugar Free. With nine locations in the Bay area, Mollie Stone’s focuses on niche, locally produced, and organic foods.

“Mollie Stone’s is committed to making a difference in people lives through food” said Stacey Rivas, Director of National Accounts for the Company. “CENTR and CENTR Sugar Free already lead the CBD beverage market in the Bay Area, as we were first to the market in 2019. We look forward to growing with Mollie Stone’s and their customers”.

About CENTR Brands Corp. CENTR Brands Corp. develops and markets non-alcoholic, functional beverages for the global market. The Company’s first product, named CENTR, is a sparkling, low-calorie, CBD beverage. For more information visit www.findyourcentr.com, and follow on Instagram at @findyourcentr.

For further information, contact Joseph Meehan at jmeehan@centrcorp.com.

On behalf of the Board,

CENTR BRANDS CORP.

/s/ Joseph Meehan
Joseph Meehan, Chairman & Chief Executive Officer

This press release may contain “Forward-Looking Statements” within the meaning of applicable Canadian securities laws. Actual results may differ from those indicated as a result of finalization of the Company’s financial statements as well as other risks and uncertainties. Such statements represent the Company’s current views with respect to future events and are necessarily based upon a number of assumptions and estimates that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political and social risks, contingencies and uncertainties. Many factors, both known and unknown, could cause results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements. The Company does not intend, and does not assume any obligation, to update these forward-looking statements or information to reflect changes in assumptions or changes in circumstances or any other events affecting such statements and information other than as required by applicable laws, rules and regulations.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/96603

Staff

Recent Posts

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

6 hours ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

9 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

9 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

9 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

9 hours ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

9 hours ago